Search

everythinglearnresearchcommunity

for

Search:↓

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

No significant genetic link to alopecia areata was found in the Jordanian group.

Cellular senescence may play a role in ALS, and anti-senescence therapies could be a promising treatment.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

The study identified key immune cell differences between mild and severe alopecia areata.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Lysophosphatidic acid boosts stem cell growth and movement by creating reactive oxygen species.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

The enzyme 25 Hydroxyvitamin D 1 α-Hydroxylase is essential for healthy skin and recovery after skin damage.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

A new mutation in the KRT86 gene causes monilethrix in a Han family.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Thymosin β4 helps with healing, inflammation, and organ protection.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

A rare ITGB6 gene variant causes intellectual disability, hair loss, and dental issues.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.